UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

February 25, 2016

Date of Report (Date of earliest event reported)

 

QUAKER CHEMICAL CORPORATION

(Exact name of Registrant as specified in its charter)

 

Commission File Number 001-12019

 

PENNSYLVANIA   No. 23-0993790
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

One Quaker Park
901 E. Hector Street
Conshohocken, Pennsylvania  19428
(Address of principal executive offices)
(Zip Code)

 

(610) 832-4000
(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

INFORMATION TO BE INCLUDED IN THE REPORT

 

Item 2.02.Results of Operations and Financial Condition.

 

On February 25, 2016, Quaker Chemical Corporation announced its results of operations for the fourth quarter and full year ended December 31, 2015 in a press release, the text of which is included as Exhibit 99.1 hereto. Supplemental information related to the same period is also included as Exhibit 99.2 hereto.

 

Item 9.01.Financial Statements and Exhibits.

 

The following exhibits are included as part of this report:

 

Exhibit No.    
99.1   Press Release of Quaker Chemical Corporation dated February 25, 2016.
     
99.2   Supplemental Information related to fourth quarter and full year ended December 31, 2015.

 

 -2- 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    QUAKER CHEMICAL CORPORATION
    Registrant
       
Date: February 25, 2016   By: /s/ Mary Dean Hall
      Mary Dean Hall
      Vice President, Chief Financial
      Officer and Treasurer

 

 -3- 

 

Exhibit 99.1

 

NEWS

 

 

Contact:
Mary Dean Hall
Vice President, Chief Financial Officer and Treasurer

Hallm@quakerchem.com

T. 610.832.4160

 

For Release: Immediate

 

QUAKER CHEMICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2015 RESULTS

 

·Operating results drive quarterly increase of 6% in adjusted EBITDA despite negative impacts of foreign exchange and lower global steel production

·Fourth quarter restructuring program expected to deliver meaningful savings beginning in 2016

·Strong quarterly cash flow leads to a 34% increase in full year operating cash flow to $73 million

 

February 25, 2016

 

CONSHOHOCKEN, PA – Quaker Chemical Corporation (NYSE: KWR) today announced net sales of $183.3 million for the fourth quarter of 2015 compared to $194.0 million for the fourth quarter of 2014 and full year net sales of $737.6 million for 2015 compared to $765.9 million for 2014. The decreases in net sales for the fourth quarter and full year 2015 were both driven by the negative impact of foreign currency translation of $12.4 million, or approximately 7%, and $53.6 million, or 7%, respectively, which more than offset volume and acquisition-related growth that the Company achieved despite challenging market conditions.

 

Earnings per diluted share decreased from $0.95 in the fourth quarter of 2014 to $0.86 for the fourth quarter of 2015, primarily due to restructuring expenses of $6.8 million, or $0.36 per diluted share, related to a global restructuring program that the Company initiated in the fourth quarter of 2015. Excluding these restructuring expenses and other uncommon items, the Company’s non-GAAP earnings per diluted share increased 16% to $1.16 for the fourth quarter of 2015 compared to $1.00 for the fourth quarter of 2014, despite the negative impact of foreign exchange of $0.05 per diluted share, or 5%, and lower global steel production. The Company’s adjusted EBITDA increased 6% to $25.3 million for the fourth quarter of 2015 from $23.8 million in the fourth quarter of 2014. Full year 2015 earnings per diluted share were $3.84 compared to $4.26 for 2014, with non-GAAP earnings per diluted share increasing 4% to $4.43 for 2015 compared to $4.26 for 2014. The Company was able to achieve this full year non-GAAP earnings growth despite the negative impact of foreign exchange of $0.31 per diluted share, or 7%, and a decline in full year global steel production. As a result of this non-GAAP earnings growth, the Company’s adjusted EBITDA increased 2% to $101.6 million for 2015 compared to $99.8 million in 2014.

 

Michael F. Barry, Chairman, Chief Executive Officer and President commented, “We are pleased to have delivered another quarter of solid earnings and strong cash flow despite a variety of market challenges. Foreign exchange headwinds continued to have the most significant negative impact on our sales and earnings and we were also challenged by global steel industry production being down over 4%. In addition, we are seeing continued weak economic conditions in several regions, especially in South America. Our sales also continued to be impacted by downward price adjustments due to lower raw material costs. Despite these market challenges, we were able to increase our non-GAAP earnings and adjusted EBITDA through additional market share gains and margin expansion.”

 

Quaker Chemical Corporation

One Quaker Park, 901 E. Hector Street, Conshohocken, PA 19428-2380 USA

P: 610.832.4000 F: 610.832.8682

quakerchem.com

 

 

 

 

Mr. Barry continued, “2015 was the sixth consecutive year of non-GAAP earnings and adjusted EBITDA growth. Looking forward, we see various headwinds that include continued uncertain economic conditions in South America and China, a strong U.S. dollar and further pricing impacts to adjust to a lower raw material cost environment. However, we remain committed to our strategy and believe our ability to continue to take market share and leverage our acquisitions will help offset these market challenges. In addition, the restructuring program we implemented in late 2015 stands to improve our SG&A leverage and yield meaningful savings, as early as the middle of 2016. Our 2016 plans indicate growth in both the top and bottom lines despite currency headwinds. Overall, I continue to remain confident in our future and expect 2016 to be another good year for Quaker, as we expect to increase non-GAAP earnings and adjusted EBITDA for the seventh consecutive year.”

 

Fourth Quarter of 2015 Summary

 

Net sales for the fourth quarter of 2015 were $183.3 million compared to net sales of $194.0 million for the fourth quarter of 2014. The decrease in net sales was primarily due to the negative impact of foreign currency translation of $12.4 million, or approximately 7%, and declines in selling price and product mix of 3%, which collectively offset a 4% increase in product volume, including sales from acquisitions.

 

Gross profit for the fourth quarter of 2015 decreased $0.8 million from the fourth quarter of 2014 due to the decrease in net sales noted above. This decrease was partially offset by an expansion of gross margin to 37.5% for the fourth quarter of 2015 compared to 35.9% for the fourth quarter of 2014, mainly due to the timing of certain raw material cost decreases in the fourth quarter of 2015 compared to the fourth quarter of 2014.

 

Selling, general and administrative expenses (“SG&A”) decreased $4.3 million in the fourth quarter of 2015 as compared to the fourth quarter of 2014 due to the net impact of several factors, including the impact of foreign currency translation, lower labor-related costs, a decrease in professional fees, and a fourth quarter of 2014 charge for a cost streamlining initiative in South America. These decreases to SG&A were partially offset by incremental costs associated with the Company’s recent acquisitions.

 

The Company had restructuring expenses of $6.8 million related to a global restructuring program initiated during the fourth quarter of 2015. Specifically, this program includes restructuring and associated costs to reduce total headcount by approximately 65 people globally and to close certain non-manufacturing locations. The Company expects to substantially complete this program in 2016, and currently projects pre-tax cost savings as a result of this program to be approximately $3 million in 2016 and approximately $6 million annually in subsequent years.

 

Other income, interest expense and interest income were relatively flat in the fourth quarter of 2015 compared to the fourth quarter of 2014. The Company had slightly higher interest expense on increased average borrowings outstanding and slightly lower third party license fees in the fourth quarter of 2015 as compared to the fourth quarter of 2014.

 

The Company’s effective tax rates for the fourth quarters of 2015 and 2014 were 16.5% and 28.5%, respectively. The primary contributors to the decrease in the fourth quarter of 2015 effective tax rate were accelerated recognition of certain tax-related credits in 2015 due to changes in local tax regulations, adjustments in the fourth quarter of 2015 related to previous years’ tax estimates, and the mix of earnings between higher and lower tax jurisdictions.

 

Equity in net income of associated companies (“equity income”) was relatively consistent in the fourth quarter of 2015 compared to the fourth quarter of 2014. The Company had lower equity income from its Venezuela affiliate in the fourth quarter of 2015 due to a first quarter of 2015 currency devaluation, which was partially offset by higher equity income from the Company’s interest in a captive insurance company.

 

The Company had a $0.2 million increase in net income attributable to noncontrolling interest in the fourth quarter of 2015 compared to the fourth quarter of 2014, primarily due to improved performance at its India affiliate.

 

During the fourth quarter of 2015, the Company recognized $0.2 million of earnings, or $0.02 per diluted share, related to its July 2015 acquisition of Verkol S.A. (“Verkol”), which was net of initial adjustments related to fair value accounting and diligence-related costs.

 

Changes in foreign exchange rates negatively impacted the Company’s fourth quarter of 2015 net income by approximately 5%, or $0.05 per diluted share.

 

- more-

 

 

 

 

Year-to-Date 2015 Summary

 

Net sales for 2015 were $737.6 million compared to net sales of $765.9 million for 2014. The decrease in net sales was primarily due to the negative impact of foreign currency translation of $53.6 million, or 7%, and declines in selling price and product mix of 1%, which collectively offset a 4% increase in product volume, including sales from acquisitions.

 

Gross profit for 2015 increased $3.8 million, or 1%, compared to 2014, driven by an expansion of gross margin to 37.6% for 2015 compared to 35.7% for 2014, partially offset by the negative impact of foreign currency translation. The increase in gross margin was mainly due to the timing of certain raw material cost decreases in 2015 compared to 2014.

 

The increase in SG&A for 2015 of $3.1 million from 2014 was due to the net impact of several factors, including higher overall labor-related costs and incremental costs associated with the Company’s recent acquisitions, including $2.8 million of one-time transaction-related expenses incurred with the Company’s third quarter of 2015 Verkol acquisition. These increases to SG&A were partially offset by decreases from foreign currency translation, a first quarter of 2014 cost related to an amendment to the Company’s pension plan in the United Kingdom (“U.K.”), and lower year-over-year charges related to cost streamlining initiatives in South America.

 

The Company had restructuring expenses of $6.8 million in 2015, noted above, related to a global restructuring program initiated in the fourth quarter of 2015. There were no analogous restructuring expenses incurred in the prior year.

 

Other income for 2015 decreased $0.8 million compared to 2014. The decrease was primarily due to lower receipts of annual government-related grants in one of the Company’s regions, higher foreign exchange transaction losses, and lower third party license fees during 2015 compared to 2014.

 

Interest expense was $0.2 million higher in 2015 compared to 2014, primarily due to higher average borrowings outstanding during 2015 due to the Company’s recent acquisition activity. Interest income was $0.9 million lower in 2015 compared to 2014, primarily due to a decrease in the level of the Company’s invested cash in certain regions with higher returns and interest received on certain tax-related credits in 2014.

 

The Company’s effective tax rates for 2015 and 2014 were 25.3% and 30.1%, respectively. The primary contributors to the decrease in the 2015 effective tax rate were the mix of earnings between higher and lower tax jurisdictions in 2015, accelerated recognition of certain tax-related credits in 2015 due to changes in local tax regulations, adjustments in 2015 related to previous years’ tax estimates, and certain one-time items that inflated the 2014 effective tax rate. Going into 2016, we expect the full year effective tax rate will increase to between 28% and 30%. In addition, the Company expects its quarterly effective tax rates will be higher in the first three quarters of 2016, similar to the 2013 quarterly effective tax rate trend, as the Company will book earnings in one of its subsidiaries at the statutory tax rate of 25% while it awaits recertification of a concessionary 15% tax rate. We currently estimate our first quarter of 2016 effective tax rate will be between 31% and 33%.

 

Equity income for 2015 decreased $3.3 million compared to 2014. The decrease was primarily due to a first quarter of 2015 currency conversion charge recorded at the Company’s Venezuela affiliate. Due to changes in Venezuela’s foreign exchange markets and currency controls, the Company re-assessed its Venezuela affiliate’s access to U.S. dollars and its ability to import or trade under the existing foreign exchange markets in the first quarter of 2015, which resulted in the 2015 charge. This was partially offset by a similar currency charge related to the conversion of Venezuelan bolivar fuerte to the U.S. dollar recorded during the second quarter of 2014. In addition, the Company had lower equity income from its interest in a captive insurance company during 2015 compared to 2014.

 

The $0.3 million decrease in net income attributable to noncontrolling interest in 2015 compared to 2014 was primarily due to the Company’s June 2014 acquisition of the noncontrolling interest in its Australia affiliate.

 

Excluding the one-time transaction-related expenses mentioned above, the Company recognized a minimal impact to net income from its 2015 Verkol acquisition, as its operating results were offset by normal acquisition-related costs and initial adjustments related to fair value accounting.

 

- more-

 

 

 

 

Changes in foreign exchange rates, excluding the currency conversion impacts of the Venezuelan bolivar fuerte noted above, negatively impacted the Company’s 2015 net income by approximately 7%, or $0.31 per diluted share.

 

Balance Sheet and Cash Flow Items

 

The Company’s net operating cash flow of $22.6 million for the fourth quarter of 2015 increased its full year net operating cash flow to $73.4 million compared to $54.7 million for 2014. The full year increase of $18.7 million, or 34%, in net operating cash flow was driven by strong operating performance and lower cash invested in the Company’s working capital during 2015. Most notably, changes in accounts receivables improved year-over-year due to the levels of sales at each year-end and improvements in timing of cash receipts. During 2015, the Company repurchased approximately 87,000 shares of its common stock for $7.3 million, pursuant to the share repurchase program announced in May of 2015. The Company has continued these share repurchases during the first quarter of 2016, with repurchases of approximately 84,000 shares at an average price of $69.8 per share for approximately $5.9 million to date. Overall, the Company’s liquidity remains strong, with net debt of $1.0 million and a consolidated leverage ratio of less than one times EBITDA.

 

Non-GAAP Measures

 

Included in this public release are non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader’s understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company’s operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. The following are reconciliations between the non-GAAP (unaudited) financial measures of non-GAAP earnings per diluted share and adjusted EBITDA to their most directly comparable GAAP financial measures:

 

   Three Months Ended
December 31,
   Twelve Months Ended
December 31,
 
   2015   2014   2015   2014 
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders  $0.86   $0.95   $3.84   $4.26 
Equity income in a captive insurance company per diluted share   (0.07)   (0.02)   (0.16)   (0.18)
Restructuring expenses per diluted share   0.36        0.36     
Verkol transaction-related expenses per diluted share           0.15     
U.K. pension plan amendment per diluted share               0.05 
Customer bankruptcy costs per diluted share   0.01    0.03    0.02    0.05 
Cost streamlining initiatives per diluted share       0.04    0.01    0.06 
Currency conversion impact of the Venezuelan bolivar fuerte per diluted share           0.21    0.02 
Non-GAAP earnings per diluted share  $1.16   $1.00   $4.43   $4.26 

 

- more-

 

 

 

 

   Three Months Ended
December 31,
   Twelve Months Ended
December 31,
 
   2015   2014   2015   2014 
Net income attributable to Quaker Chemical Corporation  $11,393   $12,639   $51,180   $56,492 
Depreciation and amortization   4,979    4,723    19,206    16,631 
Interest expense   694    624    2,585    2,371 
Taxes on income before equity in net income of associated companies   2,161    4,731    17,785    23,539 
Equity income in a captive insurance company   (857)   (270)   (2,078)   (2,412)
Restructuring expenses   6,790        6,790     
Verkol transaction-related expenses           2,813     
U.K. pension plan amendment               902 
Customer bankruptcy costs   149    515    328    825 
Cost streamlining initiatives       818    173    1,166 
Currency conversion impact of the Venezuelan bolivar fuerte           2,806    321 
Adjusted EBITDA  $25,309   $23,780   $101,588   $99,835 

 

Forward-Looking Statements

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company’s products and services is largely derived from the demand for its customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

 

Conference Call

 

As previously announced, Quaker Chemical’s investor conference call to discuss the fourth quarter and full year 2015 results is scheduled for February 26, 2016 at 8:30 a.m. (ET). A live webcast of the conference call, together with supplemental information, can be accessed through the Company’s Investor Relations website at http://www.quakerchem.com. You can also access the conference call by dialing 877-269-7756.

 

About Quaker

 

Quaker Chemical is a leading global provider of process fluids, chemical specialties, and technical expertise to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and others.  For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product quality, and lower costs through a combination of innovative technology, process knowledge, and customized services. Headquartered in Conshohocken, Pennsylvania USA, Quaker serves businesses worldwide with a network of dedicated and experienced professionals whose mission is to make a difference.

 

- more-

 

 

 

 

Quaker Chemical Corporation

Consolidated Statements of Income

(Dollars in thousands, except per share data)

 

   Three Months Ended December 31,   Twelve Months Ended December 31, 
   2015   2014   2015   2014 
                 
Net sales  $183,275   $194,033   $737,555   $765,860 
                     
Cost of goods sold   114,509    124,457    460,515    492,654 
                     
Gross profit   68,766    69,576    277,040    273,206 
%   37.5%   35.9%   37.6%   35.7%
                     
Selling, general and administrative expenses   48,753    53,091    198,990    195,850 
Restructuring and related activities   6,790    -    6,790    - 
                     
Operating income   13,223    16,485    71,260    77,356 
%   7.2%   8.5%   9.7%   10.1%
                     
Other income (expense), net   28    209    (69)   767 
Interest expense   (694)   (624)   (2,585)   (2,371)
Interest income   507    551    1,624    2,541 
Income before taxes and equity in net income of associated companies   13,064    16,621    70,230    78,293 
                     
Taxes on income before equity in net income of associated companies   2,161    4,731    17,785    23,539 
Income before equity in net income of associated companies   10,903    11,890    52,445    54,754 
                     
Equity in net income of associated companies   949    1,037    261    3,543 
                     
Net income   11,852    12,927    52,706    58,297 
                     
Less: Net income attributable to noncontrolling interest   459    288    1,526    1,805 
                     
Net income attributable to Quaker Chemical Corporation  $11,393   $12,639   $51,180   $56,492 
%   6.2%   6.5%   6.9%   7.4%
                     
Per share data:                    
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic  $0.86   $0.95   $3.84   $4.27 
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted  $0.86   $0.95   $3.84   $4.26 

 

- more-

 

 

 

 

Quaker Chemical Corporation

Consolidated Balance Sheets

(Dollars in thousands, except par value and share amounts)

 

   December 31, 
   2015   2014 
ASSETS          
           
Current assets          
Cash and cash equivalents  $81,053   $64,731 
Accounts receivable, net   188,297    189,484 
Inventories, net   75,099    77,708 
Current deferred tax assets   7,822    8,367 
Prepaid expenses and other current assets   13,582    11,228 
Total current assets   365,853    351,518 
           
Property, plant and equipment, net   87,619    85,763 
Goodwill   79,111    77,933 
Other intangible assets, net   73,287    70,408 
Investments in associated companies   20,354    21,751 
Non-current deferred tax assets   27,071    24,411 
Other assets   32,218    33,742 
Total assets  $685,513   $665,526 
           
LIABILITIES AND EQUITY          
           
Current liabilities          
Short-term borrowings and current portion of long-term debt  $662   $403 
Accounts payable   67,291    74,987 
Dividends payable   4,252    3,990 
Accrued compensation   19,166    19,853 
Accrued restructuring   6,303    - 
Accrued pension and postretirement benefits   1,144    1,239 
Current deferred tax liabilities   41    732 
Other current liabilities   25,696    23,697 
Total current liabilities   124,555    124,901 
Long-term debt   81,439    75,328 
Non-current deferred tax liabilities   15,003    8,584 
Non-current accrued pension and postretirement benefits   40,689    46,088 
Other non-current liabilities   42,584    45,490 
Total liabilities   304,270    300,391 
           
Equity          
Common stock, $1 par value; authorized 30,000,000 shares; issued and outstanding 2015 - 13,288,113 shares; 2014 - 13,300,891 shares   13,288    13,301 
Capital in excess of par value   106,333    99,056 
Retained earnings   326,740    299,524 
Accumulated other comprehensive loss   (73,316)   (54,406)
Total Quaker shareholders' equity   373,045    357,475 
Noncontrolling interest   8,198    7,660 
Total equity   381,243    365,135 
Total liabilities and equity  $685,513   $665,526 

 

- more-

 

 

 

 

Quaker Chemical Corporation

Consolidated Statements of Cash Flows

(Dollars in thousands)

 

   Twelve Months Ended December 31, 
   2015   2014 
Cash flows from operating activities          
Net income  $52,706   $58,297 
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation   12,395    12,306 
Amortization   6,811    4,325 
Equity in undistributed earnings of associated companies, net of dividends   578    (3,180)
Deferred income taxes   (2,401)   1,007 
Uncertain tax positions (non-deferred portion)   (1,122)   (1,256)
Deferred compensation and other, net   14    3,174 
Stock-based compensation   5,919    5,309 
Restructuring and related activities   6,790    - 
Gain on disposal of property, plant and equipment and other assets   (12)   (86)
Insurance settlement realized   (760)   (1,907)
Pension and other postretirement benefits   2,591    1,265 
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:          
Accounts receivable   (188)   (24,944)
Inventories   1,292    (5,484)
Prepaid expenses and other current assets   (721)   2,003 
Accounts payable and accrued liabilities   (9,040)   2,999 
Change in restructuring liabilities   (490)   - 
Estimated taxes on income   (930)   862 
Net cash provided by operating activities   73,432    54,690 
           
Cash flows from investing activities          
Investments in property, plant and equipment   (11,033)   (13,052)
Payments related to acquisitions, net of cash acquired   (24,058)   (73,527)
Proceeds from disposition of assets   135    201 
Insurance settlement interest earned   35    44 
Change in restricted cash, net   725    1,863 
Net cash used in investing activities   (34,196)   (84,471)
           
Cash flows from financing activities          
Proceeds from long-term debt   6,163    58,771 
Repayment of long-term debt   (477)   (1,368)
Dividends paid   (16,513)   (14,562)
Stock options exercised, other   1,048    804 
Payments for repurchase of common stock   (7,276)   - 
Excess tax benefit related to stock option exercises   384    453 
Purchase of noncontrolling interest in affiliates, net   -    (7,422)
Payment of acquisition-related liabilities   (226)   (4,709)
Distributions to noncontrolling affiliate shareholders   -    (1,806)
Net cash (used in) provided by financing activities   (16,897)   30,161 
           
Effect of exchange rate changes on cash   (6,017)   (4,141)
Net increase (decrease) in cash and cash equivalents   16,322    (3,761)
Cash and cash equivalents at the beginning of the period   64,731    68,492 
Cash and cash equivalents at the end of the period  $81,053   $64,731 

 

- more-

 

 

 

Exhibit 99.2

Fourth Quarter and Full Year 2015 Results Investor Conference Call February 26, 2016 Quaker Chemical Corporation

 

 

 

 

Regulation G The attached charts include Company information that does not conform to generally accepted accounting principles (“GAAP”). Management believes that an analysis of this data is meaningful to investors because it provides insight with respect to ongoing operating results of the Company and allows investors to better evaluate the financial results of the Company. These measures should not be viewed as an alternative to GAAP measures of performance. Furthermore, these measures may not be consistent with similar measures provided by other companies. This data should be read in conjunction with the Company’s fourth quarter and full year earnings news release dated February 25, 2016, which has been furnished to the SEC on Form 8-K and the Company’s Form 10-K for the year ended December 31, 2015, which has been filed with the SEC. Forward-Looking Statements This presentation may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company’s products and services is largely derived from the demand for its customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, future terrorist attacks and other acts of violence. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995. Risks and Uncertainties Statement

 

 

 

 

Speakers Michael F. Barry Chairman of the Board, Chief Executive Officer & President Mary Dean Hall Vice President, Chief Financial Officer & Treasurer Robert T. Traub Vice President, General Counsel & Corporate Secretary Chart #1

 

 

 

 

Fourth Quarter 2015 Headlines Operating results drive quarterly increase of 6% in adjusted EBITDA despite negative impacts of foreign exchange and lower global steel production Fourth quarter restructuring program expected to deliver meaningful savings beginning in 2016 Strong quarterly cash flow leads to a 34% increase in full year operating cash flow to $73 million Chart #2

 

 

 

 

Chairman Comments Fourth Quarter and Full Year 2015 Fourth Quarter / Full Year 2015 Strong margins and market share gains drive earnings and cash flow growth in the fourth quarter and full year 2015 Fourth quarter and full year results impacted by various market challenges, including foreign exchange, a decline in global steel production and weak global economic conditions, especially in South America Fourth quarter restructuring program initiated to enhance future SG&A leverage 2016 Outlook Anticipate continued uncertain economic conditions, especially in South America and China, a strong U.S. dollar, and further pricing impacts to adjust to a lower raw material cost environment Ability to take market share and leverage our acquisitions will continue to help offset these market challenges Restructuring program to yield meaningful savings as early as middle of 2016 Expect growth in both the top and bottom lines despite currency headwinds Overall, we remain confident in our future and expect 2016 to be another good year for Quaker, as we expect to increase non-GAAP earnings and adjusted EBITDA for the seventh consecutive year. Chart #3

 

 

 

 

1) Solid operating results, coupled with a low tax rate, drive fourth quarter and fullyear 2015 non-GAAP earnings per diluted share of $1.16 and $4.43 2) Fourth quarter 2015 includes restructuring expenses of $6.8 million, or $0.36 per diluted share, related to a global program to enhance SG&A leverage 3) Fourth quarter and full year 2015 net sales decreased year-over-year on negative impacts from foreign currency translation and declines in selling price and product mix, offset by volume and acquisition-related growth 4) Expansion of gross margin in the fourth quarter and full year 2015 drive improved operating performance 5) Lower fourth quarter and year-over year effective tax rates 6) Strong quarterly operating cash flows of $22.6 million drives $73.4 million for full year 2015 on operating performance and lower cash invested in working capital 7) Strong balance sheet will continue to support future growth, including acquisitions Chart #4 Financial Highlights Fourth Quarter and Full Year 2015

 

 

 

 

Financial Snapshot ($ Millions unless otherwise noted) Q4 2015 Q4 2014 FY 2015 FY 2014 Net Sales 183.3 194.0 737.6 765.9 Gross Margin 37.5 % 35.9 % 37.6 % 35.7 % Operating Margin 7.2 % 8.5 % 9.7 % 10.1 % Net Income attributable to Quaker Chemical Corporation 11.4 12.6 51.2 56.5 Earnings Per Diluted Share 0.86 0.95 3.84 4.26 Non-GAAP Earnings Per Diluted Share 1.16 1.00 4.43 4.26 Adjusted EBITDA 25.3 23.8 101.6 99.8 Adjusted EBITDA Margin 13.8 % 12.3 % 13.8 % 13.0 % Net Debt 1.0 11.0 -- -- Net Operating Cash Flow 22.6 16.7 73.4 54.7 Effective Tax Rate 16.5 % 28.5 % 25.3 % 30.1 % Chart #5

 

 

 

 

Product Volume by Quarter and Year Thousand Kilograms Chart #6 Six consecutive years of organic and acquisition-related volume growth 115,000 135,000 155,000 175,000 195,000 215,000 235,000 25,000 31,000 37,000 43,000 49,000 55,000 61,000 Full Year Volume Quarter Volume Quarter Volume Full Year Volume

 

 

 

 

Gross Margin Percentage 28.0% 34.7% 35.4% 32.6% 33.7% 35.8% 35.7% 37.6% 20.0% 25.0% 30.0% 35.0% 40.0% 2008 2009 2010 2011 2012 2013 2014 2015 Gross Margin Percentage 35.9% 36.6% 38.4% 37.7% 37.5% 20.0% 25.0% 30.0% 35.0% 40.0% Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Gross Margin Percentage Chart #7 Improvement in 2015 driven by timing of raw material cost decreases

 

 

 

 

Adjusted EBITDA Baseline Historical Performance $40.1 $66.8 $73.0 $80.9 $89.6 $99.8 $101.6 $44.2 11. 4% 13 . 0% 12 . 3% 9 . 8% 10 . 7% 12 . 3% 6 . 9% 13 . 8% 2008 2009 2010 2011 2012 2013 2014 2015 Adjusted EBITDA ($ Mi l s. ) Adjusted EBITDA Margin (%) 2008 – 2015 CAGR: 14.2% +690 Margin bps Chart #8

 

 

 

 

Balance Sheet Cash and Debt -$120 -$80 -$40 $0 $40 $80 $120 2008 2009 2010 2011 2012 2013 2014 2015 $ Millions Cash ST/LT Debt Net Debt Chart #9 Strong cash flow improves Net Debt to $1 million. Balance Sheet strength supports growth.

 

 

 

 

APPENDIX

 

 

 

 

Non-GAAP Earnings Per Diluted Share Reconciliation Chart #10 Q4 2015 Q4 2014 Full Year 2015 Full Year 2014 GAAP earnings per diluted share $ 0.86 $ 0.95 $ 3.84 $ 4.26 Equity income in a captive insurance company per diluted share $ (0.07) $ (0.02) $ (0.16) $ (0.18) Restructuring expenses per diluted share $ 0.36 $ - $ 0.36 $ - Verkol transaction-related expenses per diluted share $ - $ - $ 0.15 $ - U.K. pension plan amendment per diluted share $ - $ - $ - $ 0.05 Customer bankruptcy costs per diluted share $ 0.01 $ 0.03 $ 0.02 $ 0.05 Cost streamlining initiatives per diluted share $ - $ 0.04 $ 0.01 $ 0.06 Currency conversion impact of the Venezuelan bolivar fuerte per diluted share $ - $ - $ 0.21 $ 0.02 Non-GAAP earnings per diluted share $ 1.16 $ 1.00 $ 4.43 $ 4.26

 

 

 

 

Adjusted EBITDA Reconciliation Chart #11 2008 2009 2010 2011 2012 2013 2014 2015 Net income 9,833 16,058 32,120 45,892 47,405 56,339 56,492 51,180 Depreciation 10,879 9,525 9,867 11,455 12,252 12,339 12,306 12,395 Amortization 1,177 1,078 988 2,338 3,106 3,445 4,325 6,811 Interest expense 5,509 5,533 5,225 4,666 4,283 2,922 2,371 2,585 Taxes on income 4,977 7,065 12,616 14,256 15,575 20,489 23,539 17,785 Equity loss (income) from a captive insurance company 1,299 1 62 (313) ( 2,323) ( 1,812) (5,451) (2,412) (2,078) Non-cash gain from the purchase of an equity affiliate - - - (2,718) - - - - Equity affiliate out of period charge - - 5 64 - - - - - Restructuring expenses 2,916 2,289 - - - - - 6,790 Transition costs related to key employees 3,505 2,443 1,317 - 6 09 - - - Verkol transaction-related expenses - - - - - - - 2,813 U.K. pension plan amendment - - - - - - 902 - Customer bankruptcy costs - - - - 1,254 - 825 328 Cost streamlining initiatives - - - - - 1,419 1,166 1 73 Non-income tax contingency charges - - 4,132 - - 796 - - Change in acquisition-related earnout liability - - - (595) ( 1,737) (497) - - Mineral oil excise tax refund - - - - - (2,540) - - Currency conversion impacts of the Venezuelan bolivar fuerte - - 3 22 - - 357 321 2,806 Adjusted EBITDA 40,095 44,153 66,838 72,971 80,935 89,618 99,835 101,588 Adjusted EBITDA Margin 6.9% 9.8% 12.3% 10.7% 11.4% 12.3% 13.0% 13.8%